» Articles » PMID: 17803008

Central Sleep Apnea on Commencement of Continuous Positive Airway Pressure in Patients with a Primary Diagnosis of Obstructive Sleep Apnea-hypopnea

Overview
Specialties Neurology
Psychiatry
Date 2007 Sep 7
PMID 17803008
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Central sleep apnea (CSA) may occur in patients with snoring and obstructive sleep apnea-hypopnea (OSAH) during commencement of continuous positive airway pressure (CPAP) therapy. The presence of CSA may limit the effectiveness of CPAP therapy. The aims of this study were to assess the prevalence of CSA amongst patients starting CPAP for OSAH and to identify possible predictors of this condition.

Methods: We reviewed the polysomnograms (PSGs) and clinical records of 99 consecutive patients with a primary diagnosis of OSAH who were referred for an in-laboratory CPAP titration study. Patients with a CSA Index of > or =5 per hour at or near (+/-1 cm H2O) prescribed CPAP level formed the CSA-CPAP group. The remaining patients made up the noCSA-CPAP group. Demographic, baseline and CPAP titration PSG variables were compared between the 2 two groups.

Results: 13 subjects (13.1%) had CSA-CPAP. Patients with and without CSA-CPAP did not differ with respect to age or body mass index. 46% of patients with CSA-CPAP had CSA on their baseline PSGs compared with 8% in the noCSA-CPAP group (p <0.01). CSA-CPAP patients also had a higher apnea-hypopnea index (72.1 vs. 52.7 p = 0.02), a higher arousal index (43.3 vs. 29.2 p <0.01), and a higher mixed apnea index (6.8 vs. 1.3 p = 0.03), on their baseline PSGs. Therapeutic CPAP could not be determined in 2 CSA-CPAP patients due to a very high frequency (of severe) central apneas. In the remaining 11, the CPAP prescription to eliminate obstructive events was higher than in the noCSA-CPAP group (11.0 vs. 9.3 p = 0.08). AHI was greater both at or near prescribed CPAP (48.8 vs. 6.7 p <0.01) and overall (47.4 vs. 14.9 p <0.01). A history of ischemic heart disease or heart failure was more frequent amongst patients with CSA-CPAP than those without (p = 0.03).

Conclusion: A significant minority of patients with a primary diagnosis of OSAH have either emergence or persistence of CSA on CPAP. Risk factors include male sex, history of cardiac disease, and CSA on baseline PSG.

Citing Articles

Sleep-Related Breathing Disorders and Lower Urinary Tract Dysfunction in Children and Adolescents: A Scoping Review.

van Galen M, Huskens B, Tak B, von Gontard A, Didden R Neurourol Urodyn. 2025; 44(2):464-479.

PMID: 39760418 PMC: 11788972. DOI: 10.1002/nau.25652.


Central sleep apnoea: not just one phenotype.

Randerath W, Baillieul S, Tamisier R Eur Respir Rev. 2024; 33(171).

PMID: 38537948 PMC: 10966472. DOI: 10.1183/16000617.0141-2023.


The prevalence and polysomnographic characteristics of treatment-emergent central sleep apnea with obstructive sleep apnea.

Safci S Sleep Breath. 2024; 28(3):1245-1250.

PMID: 38308750 DOI: 10.1007/s11325-024-02999-1.


The prevalence of treatment-emergent central sleep apnea with mandibular advancement device therapy.

Hellemans S, Van de Perck E, Braem M, Verbraecken J, Dieltjens M, Vanderveken O J Clin Sleep Med. 2023; 19(12):2035-2041.

PMID: 37539639 PMC: 10692941. DOI: 10.5664/jcsm.10742.


Practice recommendations for the role of physiotherapy in the management of sleep disorders: the 2022 Brazilian Sleep Association Guidelines.

Frange C, Franco A, Brasil E, Hirata R, Lino J, Mortari D Sleep Sci. 2022; 15(4):515-573.

PMID: 36419815 PMC: 9670776. DOI: 10.5935/1984-0063.20220083.


References
1.
Vgontzas A, Tan T, Bixler E, Martin L, Shubert D, Kales A . Sleep apnea and sleep disruption in obese patients. Arch Intern Med. 1994; 154(15):1705-11. View

2.
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S . The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17):1230-5. DOI: 10.1056/NEJM199304293281704. View

3.
Javaheri S, Parker T, Wexler L, Liming J, Lindower P, Roselle G . Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med. 1996; 335(8):562-7. DOI: 10.1056/NEJM199608223350805. View

4.
Guilleminault C, Robinson A . Central sleep apnea. Neurol Clin. 1996; 14(3):611-28. DOI: 10.1016/s0733-8619(05)70276-0. View

5.
Wilcox I, McNamara S, Dodd M, Sullivan C . Ventilatory control in patients with sleep apnoea and left ventricular dysfunction: comparison of obstructive and central sleep apnoea. Eur Respir J. 1998; 11(1):7-13. DOI: 10.1183/09031936.98.11010007. View